Dose-Escalation Study in Advanced Colon Cancer Patients
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study is exploring different administration schedules (short versus prolonged infusion)
to optimize the safety and efficacy profile of EPO906A (patupilone) in patients with
pretreated advanced colon cancer.